News Articles 81 - 90 of 160
The Royal College of Physicians (RCP) and NHS R&D Forum launches its new report Research for all: Sharing good practice in research management.
Following the publication of Research for all by the RCP in 2016 this follow up report outlines the conditions needed to support research directors, managers, clinical and non-clinical staff and, ultimately, patients.
By way of over 50 case studies the report builds upon the recommendations for collaboration and provides real world examples of good practice to inspire both doctors and researchers alike.
The examples of good practice from NHS organisations around the country aim to help build the knowledge base for all involved in research. By recognising and addressing barriers to pursuing research, the report encourages both doctors and R&D departments to underpin research as a core activity and demonstrate how it is everyone’s responsibility.
For more information please the RCP https://www.rcplondon.ac.uk/ .
The tenure of the current BASL Trainee Representative will come to an end in September 2017. As such, BASL are now seeking expressions of interest for the position.
To apply for the position you must be a BASL Medically Qualified Member in Training and hold a national training number (NTN). The position is open to all trainees who are at least 24 months pre-CCT from September 2017.
The Trainee Representative will serve on the BASL Committee for a maximum of 2 years. They are expected to comment on all issues pertaining to training to ensure that trainee views are heard, to ensure that the annual meeting and schools of Hepatology meet trainees needs and in addition to attend BASL Committee meetings (face to face or teleconference) as well as the Annual Meeting. A working knowledge of Twitter is desirable and a strong link with the BSG trainee representative is helpful.
Please send your expressions of interest to the BASL Secretariat at Judith@execbs.com by the deadline of 17:00 Monday 17 July.
Emails should clearly have as the subject: BASL Trainee Representative Post 2017.
Candidates wishing to be considered for the post are required to provide a short personal statement containing no more than approx. 250 words explaining why you want to be the BASL Trainee Representative and what relevant skills or training you have. The personal statement should accompany your expressions of interest email where possible.
A panel comprising of three BASL committee members will review and score the applications to select the successful applicant.
The new Trainee Representative will take up their position at the next Business Meeting of the Association during the Annual Meeting in September 2017.
If you require any further information please contact Judith@execbs.com .
NICE focuses on improving treatment and diagnosis of liver disease.
People who drink too much should be sent for scans to detect early liver disease, says NICE.
Almost 1.9 million harmful drinkers in England could be sent for scans for cirrhosis by their GPs to detect disease early so treatment and lifestyle changes are more effective.
The final quality standard advises GPs to send people for scans for cirrhosis if men are drinking more than 50 units per week or 22 pints and women are drinking more than 35 units per week or 3 ½ bottles of wine.
You can view the final quality standard by clicking > here.
Access to the two recommended tests, transient elastography and acoustic radiation force impulse imaging is currently varied across England, whilst the first is available in at least 120 UK hospitals, the latter is a newer technology that is not as widespread.
Since draft, NICE has updated this standard to reflect that significant changes are needed to implement this guidance, such as a redesign of services or buying new equipment.
Read the full article on the NICE website > here.
The National Institute for Health and Care Excellence (NICE) is looking to appoint a number of people with the necessary experience and skills to fulfill the following roles:
• Appeal panel chair
• Lay member
The appeal panel is responsible for hearing appeals against our draft final recommendations in the technology appraisal (new drugs and other technologies used in the NHS) and highly specialised technologies (the evaluation of technologies for treating patients with very rare diseases and very complex healthcare needs) programmes. When an appeal is submitted an appeal panel comprising five members is drawn from those appointed to hear NICE appeals.
Appeal panel chairs must either:
• currently provide healthcare in the NHS or public health service, or
• be a patient or carer, or a member of an organisation that represents patients or carers.
The lay representative must be a patient or carer, or a member of an organisation that represents patients or carers.
Appointees will need to be able to understand the process and methods NICE uses to appraise new health technologies and to critically assess the arguments put forward by companies, professional groups and patient organisations appealing against our guidance. In addition, chairs must demonstrate the personal qualities necessary to organise, lead and control a setting in which sometimes complex arguments are presented and challenged. Appeal panels are established infrequently and appointees may only need to sit on a panel two to three times a year.
NICE would welcome applicants from all interested parties. For further information on the role and how apply please refer to the NICE website: https://www.nice.org.uk/Get-Involved/join-a-committee . Alternatively you can contact Maria Pitan, Project Manager – Corporate Office by email email@example.com.
The deadline for applications is 5pm on Monday 17 July 2017.
The Royal College of Physicians (RCP) has officially launched its new exemplar liver accreditation programme, Improving Quality in Liver Services (IQILS), led by Dr James Ferguson, clinical lead for the programme.
Born out of the successful LiverQuest pilot project, IQILS is supported by the British Association for the Study of the Liver (BASL) and the British Society of Gastroenterology (BSG) and has been shaped in partnership with the wider liver community, professional bodies, societies and patient groups.
Having taken learning and recommendations from the original LiverQuest pilot, the new accreditation scheme, will support liver services to deliver high-quality care for patients.
IQILS is open to all liver services across the UK, enabling them invaluable access to a new online tool, expertise and up to date guidance on improving standards and enhancing patient experience.
Thanks to the kind support of BASL, some services may also be eligible for an early bird discount.
For more details regarding the scheme, how to sign up, and discount eligibility, information can be found at www.iqils.org .
Alternatively, contact Madeline Corrigan, IQILS Programme Manager at the RCP at firstname.lastname@example.org .
We are pleased to announce that the liver disease quality standard (QS152) has been published on the NICE website today.
You can view the quality standard by clicking > here.
BASL has formally supported the liver disease quality standard.
The Alcohol-Related Liver Disease (ARLD) PSP has been set up to identify unanswered questions about alcohol-related liver disease treatments from the point of view of patients, carers and healthcare professionals.
The identified questions will be prioritised, resulting in a list of the Top 10 priorities for research.
The objectives of the ARLD PSP are to:
• work with patients and clinicians to identify uncertainties about the effects of alcohol-related liver disease prevention and treatments
• to agree by consensus a prioritised list of those uncertainties for research
• to publicise the results of the PSP and process to the research community
• to take the results to the research commissioning bodies to be considered for funding.
Formed by the James Lind Alliance and funded by the National Institute for Health Research (NIHR) and the British Society of Gastroenterology (BSG), the PSP is being guided by a steering group of patient, carer and clinical group representatives.
Download the report Alcohol Related Liver Disease PSP Final Report here: Download Alcohol-related Liver Disease PSP final report.pdf
Or visit the website to view the report by clicking > here.
Responding to the announcement (below) that the Welsh government is set to legislate for a minimum price for alcohol, Professor Sir Ian Gilmore, chair of the Alcohol Health Alliance UK (AHA), said:
“We welcome the Welsh government’s announcement today that it will introduce legislation to set a minimum price for alcohol.
“The cheaper alcohol is, the more alcohol-related harm is done, and at present there is a proliferation of cheap alcohol across the UK. Raising the price of the cheapest alcohol by setting a price below which it cannot be sold will save lives, reduce hospital admissions and cut crime.
“With Scotland also set to introduce minimum unit pricing, it is vital that the UK government now legislates for minimum unit pricing for England too, something it committed to doing five years ago but failed to follow through. With lives being lost as a direct result of freely available cheap alcohol, a decision to delay further will be in effect a death sentence for some of the most vulnerable in society.”
About the Alcohol Health Alliance UK
The Alcohol Health Alliance UK (AHA) is a group of 50 organisations including the Royal College of Physicians, Royal College of GPs, British Medical Association, Alcohol Concern and the Institute of Alcohol Studies.The AHA works together to:
• Highlight the rising levels of alcohol-related health harm
• Propose evidence-based solutions to reduce this harm
• Influence decision makers to take positive action to address the damage caused by alcohol misuse
For further information, please contact Matt Chorley, the AHA’s Policy and Communications Officer, at email@example.com or on 0203 075 1726.
Deadline: Friday 4th August 2017
Each year BASL presents the Dame Sheila Sherlock research prize, one of the highlights of the annual meeting. This prize is awarded annually to recognise the enormous contribution of Dame Sheila Sherlock to the development of Hepatology as a discipline in its own right.
When Dr Sherlock started her medical career, little was known about liver disease. Her work helped to establish hepatology as a medical specialty. She pioneered the use of needle liver biopsy, which had been used purely as a research tool, based on the technique of Sir John McMichael; this improved understanding of the pathology of liver disease and is used in the diagnosis of liver diseases today. The liver unit that she set up at the Royal Free Hospital became the centre for both research into liver disease and the education of trainees in the specialty.
Dame Sheila was involved in the foundation of the British Liver Club in 1961, which subsequently evolved into The British Association for the Study of the Liver (BASL). She was one of our past presidents and the first recipient of The BASL Distinguished Service Award.
In keeping with Dame Sheila’s enthusiasm for fostering young researchers, this eponymous research prize is awarded to young investigators without substantive posts in either medicine or science for their research contributions in the field of Hepatology.
The winner of the award will deliver a lecture presenting their research during the Annual Meeting, 20-22 September 2017. This year the prize is free registration to the meeting, a place at the Annual Dinner at Warwick Castle and £1,000.
To apply, please send one A4 sheet outlining the research and another A4 sheet detailing the related publications.
Please send submissions to firstname.lastname@example.org before the deadline of midday on Friday 4th August 2017.